Andrew Whitelaw

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Catharina Boehme, Mark P. Nicol, Pamela Nabeta et al. · The Lancet · 2011 · 1K citations · Full text

Public Health, Internal Medicine, Diagnostic Microbiology +16

Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries

Kirsty Sands, Maria J. Carvalho, Edward Portal et al. · Nature Microbiology · 2021 · 450 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries

Yingfen Hsia, Brian Lee, Ann Versporten et al. · The Lancet Global Health · 2019 · 362 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17

MYTH OF THE MARSUPIAL MOTHER: HOME CARE OF VERY LOW BIRTH WEIGHT BABIES IN BOGOTA, COLOMBIA

Andrew Whitelaw, K Sleath · The Lancet · 1985 · 324 citations

Medicine, Maternal Health, Pediatrics +12

Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis

Anna Vassall, Sanne van Kampen, Hojoon Sohn et al. · PLoS Medicine · 2011 · 315 citations · Full text

Public Health, Health Policy, Preventive Medicine +17